| BAPN | beta-aminoproprionitrile fumarate |
|---|---|
| BAPP | beta amyloid precursor protein |
| BAR | bariatrics; barometer, barometric; beta-adrenergic receptor |
| BARK | beta-adrenergic receptor kinase |
| BAS | balloon atrial septostomy; benzyl anti-serotinin; beta-adrenergic stimulation; boric acid solution |
strychnine
tazettine
thoracalgia
| 4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase | <enzyme> Not identical to human plasma lysozyme Registry number: EC 3.2.1.- Synonym: mu-tact hydrolase (26 Jun 1999) |
|---|---|
| 4-nitrophenyl beta-galactoside hydrolase | <enzyme> From biomphalaria glabrata; does not act on galactans Registry number: EC 3.2.1.- Synonym: para-nitrophenyl beta-galactoside hydrolase, 4-nitrophenyl-beta-d-galactosidase (26 Jun 1999) |
| 5 beta-cholestane-3 alpha,7 alpha-diol 26-hydroxylase | <enzyme> Nadp-dependent Registry number: EC 1.14.13.- (26 Jun 1999) |
| 6-ethanoylamino-4-methylumbelliferyl-beta-glucosidase | <enzyme> A soluble lysosomal enzyme with a discrete isoelectric point of about 5.0; hydrolyzes 6-ethanoylamino-4-methylumbelliferyl-beta-d-glucoside Registry number: EC 3.2.1.- Synonym: emglc-ase (26 Jun 1999) |
| 6-phospho-beta-glucosidase | <enzyme> Catalyses the conversion of 6-phospho-beta-d-glucosyl-(1,4)-d-glucose and h2o to d-glucose-6-phosphate and d-glucose; do not confuse with bgla gene product from rhodothermus which catalyses the reaction of EC 3.2.1.39 (endo-1,3-beta-glucanase) Registry number: EC 3.2.1.86 Synonym: bgla gene product, bglh gene product, glvg gene product (26 Jun 1999) |
| 7 beta-hydroxysteroid dehydrogenase | <enzyme> Nadp-dependent Registry number: EC 1.1.1.- Synonym: 7beta-hos dh, 7beta-hydroxysteroid dehydrogenase (26 Jun 1999) |
| 9-beta-d-ribofuranosyladenine | <biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose. <drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm. Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min). Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients. Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use other agents to avoid these drug interactions. (15 Mar 2000) |
| 9-beta-d-ribofuranosylguanine | <biochemistry, molecular biology> The nucleoside formed by linking ribose to guanine. (18 Nov 1997) |
| 9-beta-ribofuranosylpurine | A toxic nucleoside isolated from the mushroom Agaricus nebularis and from Streptomyces sp. Synonym: 9-beta-ribofuranosylpurine, purine ribonucleoside, ribosylpurine. (05 Mar 2000) |
| furostanol glycoside 26-O-beta-glucosidase | <enzyme> From costus speciosus rhizomes; specifically cleaves the c-26-bound glucose moiety of furostanol glycosides Registry number: EC 3.2.1.- Synonym: f26g enzyme (26 Jun 1999) |
| leucyl-beta-naphthylamidase | <enzyme> Frequently used to test for leucine aminopeptidase (ec 3.4.11.1) activity; hydrolyzes naphthylamides of leucine. Registry number: EC 3.4.11.- (12 Dec 1998) |
| lignostilbene-alpha,beta-dioxygenase | <enzyme> Responsible for the cleavage of interphenyl calpha-cbeta double bonds of lignostilbene Registry number: EC 1.13.11.- Synonym: lig-dioxygenase (26 Jun 1999) |
| lithocholic acid 6 beta-hydroxylase | <enzyme> Converts lithocholic acid to murideoxycholic acid, uses NADPH Registry number: EC 1.14.13.- Synonym: cyp 3a10 (26 Jun 1999) |
| aaa disease | Endemic anaemia of ancient Egypt, ascribed in the Papyrus Ebers to intestinal infestation with ancylostoma; now called ancylostomiasis. (05 Mar 2000) |
| ABO haemolytic disease of the newborn | Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes. (05 Mar 2000) |